Home Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
 

Keywords :   


Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting

2014-07-02 10:27:34| drugdiscoveryonline Home Page

Euroscreen, a private drug development company, announced today that its ESN364 Phase I clinical candidate, will be presented at the ICE/ENDO Meeting on Sunday, June 22nd (Chicago, IL)

Tags: the health present meeting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1190's MLB
14.11 THE FIRST FINAL Blu-ray
14.11Nintendo Switch Lite
14.11Summer Eye
14.11 2014
14.11 CD DVD
14.11
14.11120(20) 12
More »